Publications
] Canadian Journal of Diabetes. Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85068840292&partnerID=MN8TOARS
BMJ Open. Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: A systematic review and meta-analysis [Internet]. 2019;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85061042887&partnerID=MN8TOARS
. Diabetologia. Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia [Internet]. 2010;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-77949264220&partnerID=MN8TOARS
. Diabetes Care. The darkening cloud of diabetes do Trends in cardiovascular risk management provide a silver lining? [Internet]. 2008;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-59249095558&partnerID=MN8TOARS
. Drug Safety. Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data” [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85152556353&partnerID=MN8TOARS
. Drug Safety. Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.” [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85132201172&partnerID=MN8TOARS
. Authors' Reply to Noguchi's comment on: ``Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data''. DRUG SAFETY. 2022;45:813-814.
. Pharmacoepidemiology and Drug Safety. Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85044325731&partnerID=MN8TOARS
. BMJ open. Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85054779701&partnerID=MN8TOARS
. Diabetes Research and Clinical Practice. The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85039789313&partnerID=MN8TOARS
. Journal of General Internal Medicine. Capsule Commentary on Franklin et al., Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85053375968&partnerID=MN8TOARS
. Pharmacoepidemiology and Drug Safety. Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85044325731&partnerID=MN8TOARS
. Scientific Reports. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85054774677&partnerID=MN8TOARS
The Lancet Diabetes and Endocrinology. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study [Internet]. 2017;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85006721048&partnerID=MN8TOARS
. Medical Practice Variations. Medical Practice Variations in Diabetes Mellitus. 2016;
. Medicine (United States). Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84978686237&partnerID=MN8TOARS
. Clinical Therapeutics. Limited Impact of Drug Exposure Misclassification from Non-Benefit Thiazolidinedione Drug Use on Mortality and Hospitalizations from Saskatchewan, Canada: A Cohort Study [Internet]. 2015;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84939996306&partnerID=MN8TOARS
Diabetes, Obesity and Metabolism. Incretin-based medications for type 2 diabetes: An overview of reviews [Internet]. 2015;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84931957090&partnerID=MN8TOARS
. Canadian Journal of Hospital Pharmacy. An introduction to the fundamentals of cohort and case-control studies [Internet]. 2014;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84928803939&partnerID=MN8TOARS
. Medical Care. Changes in thiazolidinedione use and outcomes following removal of a prior-authorization policy: Controlled time-series analysis [Internet]. 2014;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890441981&partnerID=MN8TOARS
